Summary consolidated statements of operations
in millions of US dollars
| 12 months to December 31, 2008 $'M |
12 months to December 31 2007 $'M |
|
|---|---|---|
| Revenues: | ||
| Product sales | 2,754.2 | 2,170.2 |
| Royalties | 245.5 | 247.2 |
| Other revenues | 22.5 | 18.9 |
| Total revenues | 3,022.2 | 2,436.3 |
| Costs and expenses: | ||
| Cost of product sales | 408.0 | 320.3 |
| Research and development | 526.6 | 576.4 |
| Selling, general and administrative | 1,422.9 | 1,178.8 |
| Integration costs | 10.3 | 1.3 |
| Gain on sale of product rights | (20.7) | (127.8) |
| In-process R&D charge | 263.1 | 1,866.4 |
| Total operating expenses | 2,610.2 | 3,815.4 |
| Operating income/(loss) | ||
| Interest income | 412.0 | (1,379.1) |
| Interest expense | (139.0) | (70.8) |
| Other (expenses)/income, net | (32.9) | 1.2 |
| Total other expenses, net | (146.4) | (19.0) |
| Income/(loss) from continuing operations before income taxes, minority interest and equity in earnings of equity method investees |
265.6 | (1,398.1) |
| Income taxes | (98.0) | (55.5) |
| Minority interest | 3.6 | - |
| Equity in earnings of equity method investees, net of taxes | 2.4 | 1.8 |
| Income/(loss) from continuing operations | 173.6 | (1,451.8) |
| Loss from discontinued operations, net of taxes | (17.6) | - |
| Net income/(loss) | 156.0 | (1,451.8) |
| Earnings per share - basic | ||
| Income/(loss) from continuing operations | 32.1¢ | (268.7¢) |
| Loss from discontinued operations | (3.2¢) | - |
| Earnings/(loss) per Ordinary share - basic | 28.8¢ | (268.7¢) |
| Earnings per share — diluted | ||
| Income/(loss) from continuing operations | 31.8¢ | (268.7¢) |
| Loss from discontinued operations | (3.2¢) | - |
| Earnings/(loss) per Ordinary share-diluted | 28.6¢ | (268.7¢) |
| Earnings/(loss) per ADS-diluted | 85.8¢ | 806.1¢ |
| Weighted average number of shares: | Millions | Millions |
| Basic | 541.6 | 540.3 |
| Diluted | 545.4 | 540.3 |